CL
CLV.AU Clover Corporation Ltd
- Market cap
- AUD 167M
- P/E
- 16.7x
- P/B
- 2.14x
- ROE
- 13.4%
- Dividend yield
- 2.00%
- Fundamental score
- 3.0/5
Ratios use the latest price and the fiscal year ending Jul 2026.
Is CLV.AU undervalued?
Graham numberCLV.AU trades 26.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Clover Corporation Ltd fundamental analysis
15 of 22 checks passedROE 1/2
Moderate return on equity (13.4%), between 10% and 20%.
ROA 1/1
Return on assets (10.7%) is above the industry median (-35.4%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (49.1%) is above the 5-year average (11.7% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (49.1%) is above the industry median (-12.5%).
Revenue Growth 1/2
Revenue grew 6.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (1.4%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 454.1x against interest expense, well covered.
PE vs Market 0/1
PE (16.7x) is above the market median (15.0x).
PE vs Industry 0/1
PE (16.7x) is above the industry median (12.5x).
PBV 1/1
Price to book (2.1x) is below the industry median (2.2x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 35.7, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 1.43, above 1.
Dividend Yield 0/2
Dividend yield (2.0%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 31.9%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Clover Corporation Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Clover Corporation Ltd
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products…
Full company profileClover Corporation Ltd financial statements
Clover Corporation Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 47.9M | 63.0M | 76.7M | 88.3M | 60.5M | 70.7M | 79.9M | 62.2M | 86.0M | 97.4M |
| Gross Profit | 11.6M | 18.2M | 23.9M | 29.7M | 18.2M | 21.7M | 23.7M | 16.9M | 26.2M | 34.0M |
| Operating Income | 5.49M | 9.25M | 13.2M | 18.4M | 9.52M | 11.2M | 9.96M | 3.07M | 8.33M | 16.3M |
| EBITDA | 5.49M | 10.7M | 14.7M | 19.0M | 10.2M | 11.7M | 10.0M | 3.98M | 12.2M | 17.8M |
| Net Income | 3.64M | 7.59M | 10.1M | 12.5M | 6.00M | 7.13M | 6.21M | 1.52M | 7.02M | 10.5M |
| EPS | 0.02 | 0.05 | 0.06 | 0.07 | 0.04 | 0.04 | 0.04 | 0.01 | 0.04 | 0.06 |
| Balance Sheet | ||||||||||
| Total Assets | 42.6M | 52.1M | 74.8M | 81.5M | 78.7M | 90.8M | 86.2M | 84.4M | 86.8M | 97.8M |
| Total Liabilities | 10.1M | 13.9M | 29.6M | 23.9M | 20.3M | 27.7M | 19.1M | 17.3M | 14.6M | 19.8M |
| Shareholders' Equity | 32.6M | 38.1M | 45.1M | 57.6M | 58.4M | 63.0M | 67.2M | 67.1M | 72.2M | 78.0M |
| Cash & Short-term Investments | 5.92M | 7.89M | 8.27M | 9.24M | 9.09M | 10.1M | 9.44M | 12.3M | 8.68M | 7.22M |
| Total Debt | - | 4.19M | 13.5M | 14.6M | 14.2M | 12.1M | 11.7M | 10.4M | 2.42M | 1.07M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -595K | 4.08M | 4.79M | 6.66M | 8.23M | 7.85M | 6.74M | 8.45M | 8.29M | 4.39M |
| Capital Expenditure | 480K | 4.23M | 108K | 556K | 1.83M | 1.60M | 1.64M | 2.33M | 1.34M | 1.07M |
| Free Cash Flow | -1.08M | -145K | 4.68M | -556K | -1.83M | 6.25M | -1.64M | 6.13M | 6.95M | 3.32M |
| Ratios | ||||||||||
| ROE | 11.2% | 19.9% | 22.4% | 21.7% | 10.3% | 11.3% | 9.2% | 2.3% | 9.7% | 13.4% |
| ROA | 8.5% | 14.6% | 13.5% | 15.3% | 7.6% | 7.9% | 7.2% | 1.8% | 8.1% | 10.7% |
| Net Profit Margin | 7.6% | 12.1% | 13.2% | 14.1% | 9.9% | 10.1% | 7.8% | 2.4% | 8.2% | 10.7% |
| Debt to Equity | - | 0.11x | 0.30x | 0.25x | 0.24x | 0.19x | 0.17x | 0.15x | 0.03x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Clover Corporation Ltd dividends
- Dividend yield
- 2.00%
- Forward dividend
- 0.03 AUD
- Payout ratio
- 31.9%
- Ex-dividend date
- Oct 20, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 3.34M | 0.02 | 31.9% |
| 2025 | AUD 2.51M | 0.02 | 35.7% |
| 2024 | AUD 1.25M | 0.01 | 82.6% |
| 2023 | AUD 2.92M | 0.02 | 47.0% |
| 2022 | AUD 1.66M | 0.01 | 23.3% |
| 2021 | AUD 4.99M | 0.03 | 83.1% |
| 2020 | AUD 2.91M | 0.02 | 23.3% |
| 2019 | AUD 3.10M | 0.02 | 30.7% |
| 2018 | AUD 2.07M | 0.01 | 27.2% |
| 2017 | AUD 1.24M | 0.01 | 34.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Clover Corporation Ltd
- Insiders 24.19%
- Institutions 20.18%
- Public & others 55.64%
- Shares outstanding 167M
- Free float 122M
Top funds holding CLV.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| DFA Asia Pacific Small Company Series | 365K | 0.22% | - | Jan 2021 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 54.9K | 0.03% | - | Feb 2021 |
| John Hancock Fds II-International Small Company Fund | 51.5K | 0.03% | - | Jan 2021 |
| DFA International Core Equity Portfolio | 41.2K | 0.02% | - | Jan 2021 |
| DFA Investment Dimensions-DFA International Small Cap Growth Port | 41.1K | 0.02% | - | Jan 2021 |
| Brighthouse Fds Tr II-BH/Dimensional International Small Co Port | 39.9K | 0.02% | - | Dec 2020 |
| Old Westbury Small & Mid Cap Strategies Fund | 37.6K | 0.02% | - | Jan 2021 |
| DFA Investment Dimensions-World Ex U.S. Core Equity Port | 24.5K | 0.01% | - | Jan 2021 |
| DFA Investment Dimensions-DFA Va International Small | 15.2K | 0.01% | - | Jan 2021 |
| DFA International Sustainability Core 1 Portfolio | 9.22K | 0.01% | - | Jan 2021 |
Clover Corporation Ltd company profile
- Company name
- Clover Corporation Ltd
- Ticker
- CLV.AU
- ISIN
- AU000000CLV2
- Exchange
- Australian Securities Exchange
- Sector
- Consumer Defensive
- Industry
- Chemicals
- Employees
- 81
- Fiscal year end
- July
- Address
- 39 Pinnacle Road, Altona North, VIC, Australia, 3025
- Phone
- 61 3 8347 5000
- Website
- clovercorp.com.au
About Clover Corporation Ltd
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
Clover Corporation Ltd management
5- Mr. Peter J. Davey GAICD, gradDip Bus., MBACEO, MD & Executive Director
- Mr. Andrew G. M. Allibon C.A.CFO & Company Secretary
- Mr. David PierottiDirector of Operations
- Mr. Bassam HallakDirector of Sales & Marketing
- Ms. Anne Roach B.A.General Manager of People & Culture